Ethnicity and Antipsychotic Response

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Annals of Pharmacotherapy

• Publication date

  1997-11-01

• Fields of study

  Sociology, Medicine

• Identifiers
  DOI 10.1177/106002809703101114PMID 9391692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients

  2004cited by this paper
• Pimozide in the treatment of newly admitted schizophrenic patients

  2004cited by this paper
• Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance

  2004cited by this paper
• Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine

  2004cited by this paper
• Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services.

  1996cited by this paper
• Ethnicity and antidepressant response.

  1996cited by this paper
• Clinical importance of genetic polymorphism of drug oxidation.

  1996cited by this paper
• The impact of ethnicity on response to antihypertensive therapy.

  1996cited by this paper
• Newer antidepressants and the cytochrome P450 system.

  1996cited by this paper
• Ethnicity and antidepressant response.

  1996cited by this paper
• Ethnicity and psychopharmacology in latin America.

  1996cited by this paper
• Ethnicity and psychopharmacology in latin America.

  1996cited by this paper
• Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia.

  1996cited by this paper
• Ethnicity and pharmacogenetics.

  1996cited by this paper
• Neuroleptic dosing in Hispanic and Asian Inpatients with schizophrenia.

  1996cited by this paper
• Recruiting and retaining low-income Latinos in psychotherapy research.

  1996cited by this paper
• Ethnicity and pharmacogenetics.

  1996cited by this paper
• High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.

  1996cited by this paper
• Gender differences in psychotropic medications.

  1996cited by this paper
• "It's the genes, stupid". Molecular bases and clinical consequences of genetic cytochrome P450 2D6 polymorphism.

  1995cited by this paper
• Dextromethorphan Polymorphic Hepatic Oxidation (CYP2D6) in Healthy Black American Adult Subjects

  1995cited by this paper
• Smokers' baseline characteristics in the COMMIT trial.

  1995cited by this paper
• Ethnicity and psychopharmacology. Bridging the gap.

  1995cited by this paper
• Acute effects of alcohol on P300 in Asians with different ALDH2 genotypes.

  1995cited by this paper
• Phenytoin disposition and toxicity: role of pharmacogenetic and interethnic factors.

  1995cited by this paper
• Demographic and socioeconomic links to cigarette smoking.

  1995cited by this paper
• Food choices of whites, blacks, and Hispanics: data from the 1987 National Health Interview Survey.

  1995cited by this paper
• The effects of race on diagnosis and disposition from a psychiatric emergency service.

  1995cited by this paper
• Differences in Asian and white drinking: consumption level, drinking contexts, and expectancies.

  1995cited by this paper
• Dietary intake among Mexican-American women: generational differences and a comparison with white non-Hispanic women.

  1995cited by this paper
• Dietary practices, alcohol consumption, and smoking behavior: ethnic, sex, and acculturation differences.

  1995cited by this paper
• Monitoring of serum haloperidol.

  1994cited by this paper
• Hispanic/white differences in dietary fat intake among low educated adults and children.

  1994cited by this paper
• Age, environmental factors and drug metabolism.

  1994cited by this paper
• Race and tardive dyskinesia among outpatients at a CMHC.

  1994cited by this paper
• Random assignment to three haloperidol plasma levels for acute psychosis

  1994cited by this paper
• Exploring factors influencing alcohol consumption patterns among Chinese and Caucasians.

  1994cited by this paper
• Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia.

  1994cited by this paper
• Minimum effective dose of haloperidol in treatment of psychoses

  1994cited by this paper
• Relationship between age and drinking patterns and drinking problems among Japanese, Japanese-Americans, and Caucasians.

  1994cited by this paper
• Behavioural correlates of alcohol intoxication.

  1993cited by this paper
• Beyond liver and culture: a review of theories and research in drinking among Chinese in North America.

  1993cited by this paper
• Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents

  1993cited by this paper
• Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong.

  1992cited by this paper
• Major Histocompatibility Complex Associations with Clozapine-Induced Agranulocytosis

  1992cited by this paper
• Neuroleptic Prescription for Chinese Schizophrenics in Hong Kong

  1992cited by this paper
• Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects

  1991cited by this paper
• Thiothixene pharmacokinetic interactions: a study of hepatic enzyme inducers, clearance inhibitors, and demographic variables.

  1991cited by this paper
• Ethnic psychopharmacology: the Hispanic and Native American perspective.

  1991cited by this paper
• Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.

  1991cited by this paper
• Dietary regulation of cytochrome P450.

  1991cited by this paper
• Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients.

  1991cited by this paper
• Effects of some compounds isolated from Chinese medicinal herbs on hepatic microsomal cytochrome P-450 and their potential biological consequences.

  1991cited by this paper
• Community mental health services for ethnic minority groups: a test of the cultural responsiveness hypothesis.

  1991cited by this paper
• The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.

  1990cited by this paper
• Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.

  1990cited by this paper
• HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.

  1990cited by this paper
• Differences in plasma binding of drugs between Caucasians and Chinese subjects

  1990cited by this paper
• Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

  1989cited by this paper
• A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.

  1989cited by this paper
• Representation of American blacks in clinical trials of new drugs.

  1989cited by this paper
• Single dose pharmacokinetics of fluphenazine decanoate

  1989cited by this paper
• Antipsychotic drugs in schizophrenia: current issues.

  1988cited by this paper
• Haloperidol and prolactin concentrations in Asians and Caucasians.

  1988cited by this paper
• Influences of Diet and Nutrition on Clinical Pharmacokinetics

  1988cited by this paper
• Polymorphism of the 4-Hydroxylation of Debrisoquine in the San Bushmen of Southern Africa

  1988cited by this paper
• Low frequency of slow debrisoquine hydroxylation in a native Chinese population.

  1987cited by this paper
• An analysis of steady state chlorpromazine plasma levels in the clinical setting.

  1987cited by this paper
• Persistence of Plasma Neuroleptic Levels after Drug Discontinuation

  1987cited by this paper
• Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.

  1987cited by this paper
• Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan.

  1987cited by this paper
• Utilization of health and mental health services by Los Angeles Mexican Americans and non-Hispanic whites.

  1987cited by this paper
• Ethnicity and psychopharmacology

  1986cited by this paper
• Metoprolol and debrisoquin metabolism in nigerians: Lack of evidence for polymorphic oxidation

  1986cited by this paper
• Neuroleptic dosage for Asians: a failure to replicate.

  1986cited by this paper
• Neuroleptic dosage for Asians: a failure to replicate.

  1986cited by this paper
• Effects of smoking on fluphenazine clearance in psychiatric inpatients

  1985cited by this paper
• Effects of carbamazepine on plasma haloperidol levels.

  1985cited by this paper
• Effects of Ethanol on Drug and Metabolite Pharmacokinetics

  1985cited by this paper
• Effects of smoking on fluphenazine clearance in psychiatric inpatients.

  1985cited by this paper
• Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

  1985cited by this paper
• [Alcohol, alcoholism and drugs].

  1985cited by this paper
• Dissociation of co‐regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians

  1985cited by this paper
• Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians

  1984cited by this paper
• Haloperidol concentrations elevated in Chinese patients.

  1984cited by this paper
• Dissimilar dosing with high-potency and low-potency neuroleptics.

  1984cited by this paper
• Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism

  1984cited by this paper
• Diagnosis and pharmacotherapy issues in the care of Hispanics in the public sector.

  1984cited by this paper
• Race, violence, and psychopathology.

  1984cited by this paper
• Mechanism(s) of ethanol-drug interaction.

  1984cited by this paper
• Diagnosis and pharmacotherapy issues in the care of Hispanics in the public sector.

  1984cited by this paper
• Neuroleptic dosage for Asians.

  1983cited by this paper
• Misdiagnosis of schizophrenia in bipolar patients: a multiethnic comparison.

  1983cited by this paper
• Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report.

  1983cited by this paper
• Cigarette smoking and chlorpromazine disposition and actions

  1982cited by this paper
• Ethnic Differences in Drug Metabolism

  1982cited by this paper
• Extrapyramidal reactions in Asians.

  1981cited by this paper
• Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Behavioral considerations.

  1981cited by this paper
• Overview: white norms and psychiatric diagnosis of black patients.

  1981cited by this paper
• A study of the debrisoquine hydroxylation polymorphism in a Nigerian population.

  1980cited by this paper

• Racial and Ethnic Considerations for the Clinical Practice of Psychopharmacology and Research Methodology: A Narrative Review of the Growing Body of Literature

  2025cites this paper
• Use and Discontinuation Rates of Long‐Acting Injectable Antipsychotics Between Race/Ethnicity in Older Adults Using Medicaid Databases

  2025cites this paper
• Antipsychotic prescription patterns among schizophrenia patients in Guangdong Province, China’s 686 program: A retrospective study

  2024cites this paper
• Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board

  2023cites this paper
• Ethnic Differences in Antipsychotic treatment responses in Early Intervention in Psychosis

  2021cites this paper
• Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6‐week, randomized, double‐blind, placebo‐controlled study

  2021cites this paper
• Addressing Structural Racism in Psychiatry With Steps to Improve Psychophysiologic Research.

  2021cites this paper
• Ef fi cacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study

  2021cites this paper
• Association Between the COMT Val158Met Polymorphism and Antipsychotic Efficacy in Schizophrenia: An Updated Meta-Analysis

  2020cites this paper
• Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey.

  2019cites this paper
• The effect of ethnicity and immigration on treatment resistance in schizophrenia.

  2019cites this paper
• Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review

  2017cites this paper
• Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features

  2017cites this paper
• CHAPTER 4 MISSENSE POLYMORPHISMS IN THREE OXIDATIVE-STRESS ENZYMES ( GSTP 1 , SOD 2 , AND GPX 1 ) AND DYSKINESIAS IN RUSSIAN PSYCHIATRIC INPATIENTS FROM SIBERIA

  2017cites this paper
• Topiramate’s effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial

  2017cites this paper
• An Inter-Ethnic Comparison Study of Ziprasidone Plasma Levels, Dosage and Clinical Response in Patients with Schizophrenia

  2017cites this paper
• CHAPTER 3 TARDIVE DYSKINESIA AND DRD 3 , HTR 2 A , AND HTR 2 C GENE POLYMORPHISMS IN RUSSIAN PSYCHIATRIC INPATIENTS FROM SIBERIA

  2017cites this paper
• Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital

  2015cites this paper
• Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001–2009)

  2014cites this paper
• Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

  2014cites this paper
• The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries.

  2013cites this paper
• Untitled Page

  2012cites this paper
• Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001–2009)

  2012cites this paper
• Variation de sensibilité aux traitements psychotropes et origine génétique : à propos de huit cas de patients asiatiques

  2012cites this paper
• Prescribing patterns of low doses of antipsychotic medications in older Asian patients with schizophrenia, 2001–2009

  2012cites this paper
• Ethical Dimensions of Disparities in Depression Research and Treatment in the Pharmacogenomic Era

  2012cites this paper
• Ethnopsychopharmacology considerations for Asians and Asian Americans.

  2012cites this paper
• Structural Models Describing Placebo Treatment Effects in Schizophrenia and Other Neuropsychiatric Disorders

  2011cites this paper
• Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia

  2011cites this paper
• Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009

  2011cites this paper
• Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients

  2011cites this paper
• Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009.

  2011cites this paper
• Effect of Initial Ziprasidone Dose on Treatment Outcome of Korean Patients with Acute Manic or Mixed Episodes

  2011cites this paper
• Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia

  2011cites this paper
• Molecular Genetics and the Treatment of Addiction

  2010cites this paper
• Medication use by ethnic and racial groups: policy implications

  2010cites this paper
• Individual Variations in Dru g

  2010cites this paper
• A systematic review of hypothalamic–pituitary–adrenal axis function in schizophrenia: implications for mortality

  2010cites this paper
• Etnopsicofarmacologia. Aspetti biologici e culturali della risposta al trattamento medico in psichiatria Ethnopsychopharmacology. Biological and cultural aspects of response to medical treatment in psychiatry

  2010cites this paper
• Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia: Meta‐Analysis of 3 Randomized, Controlled Clinical Trials

  2010cites this paper
• Missense polymorphisms in three oxidative‐stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia

  2010cites this paper
• Pharmacogenetics of antipsychotic-induced Parkinsonism and tardive dyskinesia

  2009cites this paper
• The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment

  2009cites this paper
• Ziprasidone in Black Patients with Schizophrenia: Analysis of Four Short-term, Double-blind Studies

  2009cites this paper
• Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.

  2009cites this paper
• Pharmacokinetic study of cephradine in Pakistani healthy male volunteers.

  2008cites this paper
• Pharmacogenetics in psychiatry: are we ready for widespread clinical use?

  2008cites this paper
• Ethnicity and psychopharmacology

  2008cites this paper
• Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial.

  2007cites this paper
• Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic

  2007cites this paper
• Long-acting injectable risperidone in the treatment of schizophrenia in special patient populations.

  2007cites this paper
• Effectiveness and safety of olanzapine in the treatment of schizophrenia among Asian patients switching from conventional antipsychotics.

  2007cites this paper
• The Relationship between the Therapeutic Response to Antipsychotic Drugs and the Dopamine D2, D3, and D4 Receptor Gene Polymorphisms in Korean Schizophrenic Patients.

  2007cites this paper
• Biological research on drug abuse and addiction in Hispanics: current status and future directions.

  2006cites this paper
• Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia

  2006cites this paper
• Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders

  2006cites this paper
• The Interface of Multiculturalism and Psychopharmacology

  2006cites this paper
• Hispanic drug abuse research: challenges and opportunities.

  2006cites this paper
• Racial differences in medication switching and concomitant prescriptions in the treatment of bipolar disorder.

  2006cites this paper
• Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

  2006cites this paper
• Cross-cultural psychopharmacology: a current clinical perspective.

  2005cites this paper
• Avoiding Side Effects in Ethnically Diverse Patients

  2005cites this paper
• Genetics and psychopharmacology: prospects for individualized treatment.

  2005cites this paper
• Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.

  2005cites this paper
• Lack of impact of race on the efficacy and safety of long-acting risperidone versus placebo in patients with schizophrenia or schizoaffective disorder

  2005cites this paper
• The Differential Effects of Steady‐State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers

  2004cites this paper
• A CYP2D6 phenotype-genotype mismatch in Japanese psychiatric patients.

  2004cites this paper
• Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients.

  2004cites this paper
• Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

  2004cites this paper
• Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms

  2004cites this paper
• Pharmacogenetics of antipsychotic-induced parkinsonism and tardive dyskinesia: a focus on African-Caribbeans and Slavonic Caucasians

  2004cites this paper
• Nuclear Nonproliferation: A Hidden but Contentious Issue in US-Japan Relations During the Carter Administration (1977-1981)

  2003cites this paper
• Racial disparity in the pharmacological management of schizophrenia.

  2003cites this paper
• The long-acting depot antipsychotic drugs.

  2003cites this paper
• Expert opinion

  2003cites this paper
• Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States.

  2003cites this paper
• Cultural Aspects of Psychosis in the Elderly

  2003cites this paper
• Pharmacogenetics in the postgenomic era.

  2003cites this paper
• The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999.

  2002cites this paper
• Do race, gender or mode of dialysis modulate erythropoietin response?

  2002cites this paper
• Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder.

  2002cites this paper
• How Important Are Gender Differences in Pharmacokinetics?

  2002cites this paper
• Access to new medications to treat schizophrenia

  2002cites this paper
• Functionally gene-linked polymorphic regions and genetically controlled neurotransmitters metabolism.

  2001cites this paper
• Evaluation of the Bilingual Case Management Program in community mental health services in Melbourne

  2001cites this paper
• Symptomatology and Medication Monitoring for Public Mental Health Consumers: A Cultural Perspective

  2001cites this paper
• Cultural competence: cardiovascular medications.

  2001cites this paper
• Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

  2001cites this paper
• Ethnicity and psychopharmacology.

  2001cites this paper
• Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.

  2000cites this paper
• Pharmacogenetics and psychopharmacotherapy

  2000cites this paper
• Pharmacogenetics of schizophrenia.

  2000cites this paper
• Patients with schizophrenia at risk for excessive antipsychotic dosing.

  2000cites this paper
• Pharmacogenomics and schizophrenia.

  2000cites this paper
• Gender differences in pharmacokinetics and pharmacodynamics.

  1999cites this paper
• The challenges of psychopharmacogenetics.

  1999cites this paper
• Ethnic and cultural factors in psychopharmacology

  1999cites this paper
• Psicofarmacogenética: uma nova abordagem terapêutica

  1999cites this paper
• PSYCHIATRIC GENETICS '99 The Challenges of Psychopharmacogenetics

  1999cites this paper
• Culturally competent drug administration.

  1999cites this paper